1. Aethlon Medical, Inc. (AEMD)
Aethlon Medical (NASDAQ:AEMD) has been exploding of late, since the debacle started. This stock has gone, literally, from 76 cents to Monday’s high at 4.07, in the last five weeks. Monday, alone, it jumped 1.57, or 65.4%, to 3.97, on 14 million shares, and is up another 13 cents in after-hours. It is now at the major declining topsline of the last year, so be careful up here, but momentum can carry it to 5 1/4, even 6 1/2-3/4, or more.
2. Alpha Pro Tech, Ltd. (APT)
Alpha Pro Tech (NYSE:APT) maker of containment suits, has gone ballistic. It exploded with a breakaway gap just a week ago, and on Monday, it opened at 3.85, and rocketed 1.70, or 28.33%, to 7.86, before pulling back and closing at 7.70, on 11.5 million shares, nearly three times the average volume. It more than doubled and now it’s extended. Can it explode and get up to the $10-range like it did back in 2014? Sure.
3. Cleveland BioLabs, Inc. (CBLI)
Cleveland BioLabs (NASDAQ:CBLI) is a really-good company. I know them very well. You can see that they were decimated to the 50-cent range in early Dec, but recently exploded, literally going from about 52 cents to almost 5.00, in just a month. On Monday, they popped 2.78, or 211%, to 4.10, after reaching a 52-week high of 4.90, on 13.8 million shares, a more than 200% increase in the average volume on this stock. The big breakaway gap could mean it’s going into the 7-range.
4. NanoViricides, Inc. (NNVC)
NanoViricides (NYSE:NNVC) exploded, pulled back, took off again, and in just three sessions it went from 4.00 to Monday’s high at 17.77, jumping 7.35, or 87%, to 15.80, on 33 million shares. That’s huge volume for this stock. Momentum could carry it higher, but be careful if this gets into the low or mid-20’s in the next day or two, because it will be very vulnerable.
5. Relmada Therapeutics, Inc. (RLMD)
Relmada Therapeutics (NASDAQ:RLMD) has been a fantastic chart since Oct when it traded in the 9-range, and now it’s in the mid-40’s. On Monday, it was up 1.23, or 2.84%, to 44.53, after reaching a high of 44.95 for the session, on 145,029 shares trade. If this gets through the spike high from early Dec when it was 48, we’re looking at this stock to run to the mid-50’s, and then low-to-mid 60’s.
6. Meridian Bioscience, Inc. (VIVO)
Meridian Bioscience (NASDAQ:VIVO) broke out of an inverse head-and-shoulders, which was a major move today, running up 1.96, or 21%, to the early-morning, session high of 13.31, before pulling back and closing up 11.50, on 3.4 million share. It advanced another dime in after-hours. That’s huge volume for this stock. If it gets any momentum, or follow-through, this could be a 15-dollar stock.
Stocks on the long side
Aethlon Medical, Inc. (AEMD), Alpha Pro Tech, Ltd. (APT), Lakeland Industries, Inc. (LAKE), Beyond Meat, Inc. (NASDAQ:BYND), Cleveland BioLabs, Inc. (CBLI), Cidara Therapeutics, Inc. (CDTX), Compugen Ltd. (CGEN), Co-Diagnostics, Inc. (CODX), Inovio Pharmaceuticals, Inc. (INO), Neoleukin Therapeutics, Inc. (NLTX), NanoViricides, Inc. (NNVC), Novavax, Inc. (NVAX), Relmada Therapeutics, Inc. (RLMD), SeaChange International, Inc. (SEAC), VelocityShares Daily 2x VIX ST ETN (TVIX), ProShares Ultra VIX Short-Term Futures (UVXY), and Meridian Bioscience, Inc. (VIVO).